Cambrex to Participate in the Stephens Fall Investment Conference

EAST RUTHERFORD, N.J., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM) (“Cambrex”) is pleased to announce that Steven Klosk, President and Chief Executive Officer, and Gregory Sargen, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Stephens Fall Investment Conference on November 10, 2015 at 9:00 a.m. EST in New York City.

The live audio webcast and a copy of Cambrex’s Investor Presentation can be accessed from the Cambrex website at in the Investors section under “Webcasts & Presentations,” and a replay will be available for 90 days after the live event concludes.

About Cambrex

Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit

Contact:Stephanie LaFiura
Investor Relations Associate

Source:Cambrex Corporation